For our Cardiovascular offering please visit: insightracardiovascular.com

GIVE YOUR PATIENTS CONFIDENCE THAT YOUR FACILITY IS SAFE FROM HARMFUL AIRBORNE PATHOGENS

SUPPORTED BY NASA TECHNOLOGY
  • Studies indicate that aerosols are a large contributor to the continuing spread of the coronavirus. 1 & 2

  • Cleaning the air is a big part of ensuring patient and staff safety at your facility. 3

  • The FDA has recently issued a guidance document stating that air purifiers designated as FDA class II medical devices may reduce the risk of viral exposure to SARS-CoV-2 by keeping aerosol concentrations to low levels. 4 This has recently been confirmed by a number of studies. 3

  • Insightra Medical offers Airocide air purifying systems, a photocatalytic oxidation technology developed by NASA that completely destroys airborne bacteria and viruses. 5 & 6

  • Airocide is FDA approved for use in operating rooms due to its ability to destroy harmful pathogens at a molecular level – NO FILTERING and STORING of infectious micro-organisms like HEPA filters and many other air purifiers.

Airocide Benefits:

  • NASA technology developed to clean air on space stations
  • Destroys viruses, bacteria, mold, VOCs without producing ozone
  • No storing of filtered harmful micro-organisms to be disposed at a later time
  • Treated air exits as 99.999% pathogen free fresh air on the first pass. 7
  • FDA class 2 medical device approved for operating rooms
  • Only need to change reaction chamber lamps once per year – no filters to clean

Place Airocide units in waiting, consultation, operating, and recovery rooms.  Installation is simple and maintenance consists of replacing reaction chamber lamps and a particulate screen once per year.

References

  • Lednicky, John A. et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida. August 4th, 2020. https://www.medrxiv.org/content/10.1101/2020.08.03.20167395v1.

  • Morawska, Lidia, Milton, Donald K. It is Time to Address Airborne Transmission of COVID-19. Clinical Infectious Diseases, ciaa939. July 6th, 2020. https://doi.org/10.1093/cid/ciaa939

  • Kähler CJ, Hain R (2020) Fundamental protective mechanisms of face masks against droplet infections. Journal of Aerosol Science 148:105617. August 7th, 2020. https://doi.org/10.1016/j.jaerosci.2020.105617

  • The United States of America Food and Drug Administration (FDA). Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. March 2020. https://www.fda.gov/media/136533/download.

  • Self-Cleaning AiroCide Catalyst – Mineralization of E. Coli to Water Vapor and Carbon Dioxide Tested and Published by The National Renewable Energy Laboratory
  • Journal of Clinical Engineering, Peer Reviewed Published Paper Texas A&M University, College of Medicine – AiroCide In a Hospital Operating Room. April/June 2004.
  • Bacillus Anthrax Spores – University of Wisconsin & The State of Wisconsin Hygiene Laboratory Tested Bacillus Thuringiensis Spores With a 99.9986% Kill Rate In a Single Pass. NASA Published Results.

Contact Us

Insightra Medical, Inc.
141 Hatcher Ln
Clarksville, TN 37043

©2020 Insightra Medical Inc LLC | All RIghts Reserved | Site by Clarksville Website Design
0